Glucocorticoids (e.g., corticosterone; Dexamethasone, DEX), when administered systemically greatly increase water drinking elicited by angiotensin and sodium ingestion in response to mineralocorticoids (e.g., aldosterone; DOCA), possibly by acting in the brain. In addition, glucocorticoids exert powerful renal actions that could influence water and sodium ingestion by promoting their excretion. To test this, we determined water and sodium intakes, excretions, and balances during injections of DEX, DOCA and their co-administration (DOCA+DEX) at doses commonly employed to stimulate ingestion of water and sodium. In animals having only water to drink, DEX treatment greatly increased water and sodium excretion without affecting water intake, thereby producing negative water and sodium balances. Similar results were observed when DEX was administered together with DOCA. In animals having water and saline solution (0.3 M NaCl) to drink, DEX treatment increased water and sodium excretion, had minimal effects on water and sodium intakes, and was associated with negative water and sodium balances. DOCA treatment progressively increased sodium ingestion, and both water and sodium intakes exceeded their urinary excretion, resulting in positive water and sodium balances. The combination of DOCA+DEX stimulated rapid, large increases in sodium ingestion and positive sodium balances. However, water excretion outpaced total fluid intake resulting in large, negative water balances. Plasma volume increased during DOCA treatment and did not change during treatment with DEX or DOCA+DEX. We conclude that increased urinary excretion, especially of water, during glucocorticoid treatment may explain the increased ingestion of water and sodium that occurs during co-administration with mineralocorticoids.